ABILIFY TABLET
Total Payments
$16,152
Transactions
116
Doctors
60
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $66.64 | 6 | 6 |
| 2017 | $16,085 | 110 | 54 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,521 | 35 | 65.1% |
| Food and Beverage | $2,975 | 78 | 18.4% |
| Unspecified | $2,622 | 1 | 16.2% |
| Education | $33.12 | 2 | 0.2% |
Payments by Type
General
$13,529
115 transactions
Research
$2,622
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STUDY EVALUATING THE SAFETY AND EFFICACY OF FIXED-DOSE ONCE-DAILY ORAL ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER31-12-293 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,622 | 1 |
Top Doctors Receiving Payments for ABILIFY TABLET — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , DO | Psychiatry | Montgomery, AL | $12.56 | 1 |
| , MD | Psychiatry | Milwaukee, WI | $12.31 | 1 |
| , M.D | Psychiatry | Dayton, OH | $11.40 | 1 |
| , M.D | Internal Medicine | Dayton, OH | $11.40 | 1 |
| , MD | Psychiatry | Vandalia, OH | $11.40 | 1 |
| , MD | Psychiatry | Anniston, AL | $9.63 | 1 |
| , MD | Psychiatry | Temecula, CA | $7.03 | 1 |
| , M.D | Psychiatry | Russellville, AR | $1.74 | 1 |
| , M.D | Psychiatry | Westlake, OH | $1.54 | 1 |
| , MD | Child & Adolescent Psychiatry | Gainesville, FL | $0.98 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $16,152
- Total Doctors 60
- Transactions 116
About ABILIFY TABLET
ABILIFY TABLET is a drug associated with $16,152 in payments to 60 healthcare providers, recorded across 116 transactions in the CMS Open Payments database. The primary manufacturer is Otsuka Pharmaceutical Development & Commercialization, Inc..
Payment data is available from 2017 to 2018. In 2018, $66.64 was paid across 6 transactions to 6 doctors.
The most common payment nature for ABILIFY TABLET is "Travel and Lodging" ($10,521, 65.1% of total).
ABILIFY TABLET is associated with 1 research study, including "STUDY EVALUATING THE SAFETY AND EFFICACY OF FIXED-DOSE ONCE-DAILY ORAL ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER31-12-293" ($2,622).